Related Experiment Video
Updated: Jun 21, 2025

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
The E2F family: a ray of dawn in cardiomyopathy
Jinwen Wei1, Can Gao1, Changxu Lu1
1College of Exercise and Health, Shenyang Sport University, No.36 Jinqiansong East Road, Shenyang, 110102, Liaoning, People's Republic of China.
Insights
Transcription factors E2Fs are crucial in heart muscle (cardiomyopathy) diseases. This review explores E2F roles in cardiomyopathy development and their potential as therapeutic targets for better patient outcomes.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Cardiomyopathies are myocardial diseases with high morbidity and mortality.
- The E2F family of transcription factors regulates essential cellular processes like proliferation and apoptosis.
- Dysregulated E2F activity is implicated in various diseases.
Purpose of the Study:
- To review the structural and functional characteristics of E2Fs.
- To elucidate the role of E2Fs in cardiomyocyte functions.
- To explore the association between E2Fs and cardiomyopathy pathogenesis.
Main Methods:
- Literature review of studies on E2F family and cardiomyopathies.
- Analysis of E2F involvement in cardiomyocyte proliferation, differentiation, and apoptosis.
- Synthesis of evidence linking E2F dysregulation to cardiomyopathy development.
Main Results:
- E2Fs are critical regulators of cardiomyocyte homeostasis.
- Aberrant E2F activity contributes to the onset and progression of cardiomyopathies.
- E2F family members exhibit diverse roles in cardiac pathophysiology.
Conclusions:
- E2Fs are significantly implicated in the pathogenesis of cardiomyopathies.
- E2Fs present potential as diagnostic biomarkers for cardiomyopathies.
- Targeting E2Fs may offer novel therapeutic strategies for cardiomyopathy treatment.
Abstract:
Cardiomyopathies are a group of heterogeneous diseases, characterized by abnormal structure and function of the myocardium. For many years, it has been a hot topic because of its high morbidity and mortality as well as its complicated pathogenesis. The E2Fs, a group of transcription factors found extensively in eukaryotes, play a crucial role in governing cell proliferation, differentiation, and apoptosis, meanwhile their deregulated activity can also cause a variety of diseases. Based on accumulating evidence, E2Fs play important roles in cardiomyopathies. In this review, we describe the structural and functional characteristics of the E2F family and its role in cardiomyocyte processes, with a focus on how E2Fs are associated with the onset and development of cardiomyopathies. Moreover, we discuss the great potential of E2Fs as biomarkers and therapeutic targets, aiming to provide a reference for future research.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
08:38Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
Published on: July 21, 2023
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Pathophysiology of Heart Failure
Master Transcription Regulators
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal